pression of I h contributes to propofol-induced inhibition of mouse cortical pyramidal neurons. J Neurophysiol 94: [3872][3873][3874][3875][3876][3877][3878][3879][3880][3881][3882][3883] 2005. First published August 10, 2005; doi:10.1152/jn.00389.2005. The contributions of the hyperpolarization-activated current, I h , to generation of rhythmic activities are well described for various central neurons, particularly in thalamocortical circuits. In the present study, we investigated effects of a general anesthetic, propofol, on native I h in neurons of thalamus and cortex and on the corresponding cloned HCN channel subunits. Whole cell voltage-clamp recordings from mouse brain slices identified neuronal I h currents with fast activation kinetics in neocortical pyramidal neurons and with slower kinetics in thalamocortical relay cells. Propofol inhibited the fast-activating I h in cortical neurons at a clinically relevant concentration (5 M); inhibition of I h involved a hyperpolarizing shift in half-activation voltage (⌬V1/2 approximately Ϫ9 mV) and a decrease in maximal available current (ϳ36% inhibition, measured at Ϫ120 mV). With the slower form of I h expressed in thalamocortical neurons, propofol had no effect on current activation or amplitude. In heterologous expression systems, 5 M propofol caused a large shift in V1/2 and decrease in current amplitude in homomeric HCN1 and linked heteromeric HCN1-HCN2 channels, both of which activate with fast kinetics but did not affect V1/2 or current amplitude of slowly activating homomeric HCN2 channels. With GABA A and glycine receptor channels blocked, propofol caused membrane hyperpolarization and suppressed action potential discharge in cortical neurons; these effects were occluded by the I h blocker, ZD-7288. In summary, these data indicate that propofol selectively inhibits HCN channels containing HCN1 subunits, such as those that mediate I h in cortical pyramidal neuronsand they suggest that anesthetic actions of propofol may involve inhibition of cortical neurons and perhaps other HCN1-expressing cells.
The contributions of the hyperpolarization-activated current, I h , to generation of rhythmic activities are well described for various central neurons, particularly in thalamocortical circuits. In the present study, we investigated effects of a general anesthetic, propofol, on native I h in neurons of thalamus and cortex and on the corresponding cloned HCN channel subunits. Whole cell voltage-clamp recordings from mouse brain slices identified neuronal I h currents with fast activation kinetics in neocortical pyramidal neurons and with slower kinetics in thalamocortical relay cells. Propofol inhibited the fast-activating I h in cortical neurons at a clinically relevant concentration (5 M); inhibition of I h involved a hyperpolarizing shift in half-activation voltage (⌬V1/2 approximately Ϫ9 mV) and a decrease in maximal available current (ϳ36% inhibition, measured at Ϫ120 mV). With the slower form of I h expressed in thalamocortical neurons, propofol had no effect on current activation or amplitude. In heterologous expression systems, 5 M propofol caused a large shift in V1/2 and decrease in current amplitude in homomeric HCN1 and linked heteromeric HCN1-HCN2 channels, both of which activate with fast kinetics but did not affect V1/2 or current amplitude of slowly activating homomeric HCN2 channels. With GABA A and glycine receptor channels blocked, propofol caused membrane hyperpolarization and suppressed action potential discharge in cortical neurons; these effects were occluded by the I h blocker, ZD-7288. In summary, these data indicate that propofol selectively inhibits HCN channels containing HCN1 subunits, such as those that mediate I h in cortical pyramidal neuronsand they suggest that anesthetic actions of propofol may involve inhibition of cortical neurons and perhaps other HCN1-expressing cells.
I N T R O D U C T I O N
Propofol (2,6 di-isopropylphenol) is an intravenous anesthetic with a chemical structure distinct from any other anesthetic that has been gaining use for induction and maintenance of anesthesia in clinical practice during the last 10 yr. Despite this growth in popularity as an anesthetic compound, its mechanisms of action remain incompletely understood. Effects of intravenous anesthetics, including propofol, are generally thought to be mediated by GABAergic mechanisms (Rudolph and Antkowiak 2004; Trapani et al. 2000) . Indeed propofolinduced suppression of the withdrawal response to painful stimuli (i.e., its immobilizing action) was completely abolished in mice with a point mutation (N265M) engineered into the ␤3 subunit of the GABA A receptor to remove its sensitivity to propofol (Jurd et al. 2003) . Interestingly, although recovery from propofol-induced loss-of-righting reflex was accelerated in the ␤3(N265M) animals (Jurd et al. 2003) , the loss-ofrighting reflex itself was not blocked. This indicates that the direct hypnotic actions of the drug were relatively preserved in these GABA A receptor knock-in mice (Jurd et al. 2003) . The results with this mouse model are consistent with earlier pharmacological studies, which demonstrated that only the immobilizing, but not the hypnotic, effects of propofol are sensitive to systemic administration of GABA A receptor blockers (Little et al. 2000; Sonner et al. 2003b) .
Additional evidence indicates that propofol can mediate other clinically relevant actions independent of the GABA A receptor, perhaps via alternative ionic mechanisms. For example, anticonvulsant actions of propofol, assayed as the ability of the drug to reduce epileptiform activity in rat hippocampal slices, are insensitive to the GABA A receptor antagonist bicuculline (Ohmori et al. 2004 ). Anesthetic and anticonvulsant properties of propofol have been attributed to suppressive effects on a hyperpolarization-activated cationic current (I h ) in hippocampal pyramidal neurons (Funahashi et al. 2001; Higuchi et al. 2003) . In addition, a recent study indicates that propofol can enhance inhibitory input onto thalamocortical relay neurons, gating sensory activity through the thalamus, by blocking small conductance calcium-activated potassium (SK) channels in reticular thalamic neurons (Ying and Goldstein 2005) . Thus the overall actions of propofol may involve modulation of ion channels in addition to GABA A receptors.
There is little detailed information as to which brain regions are critical for different endpoints of anesthesia, but direct or indirect depression of neurons in thalamocortical loops may provide a point of convergence for anesthetic actions, contributing to a sleep-like hypnotic state (Alkire et al. 2000) . The pacemaker current, I h , figures prominently in the firing behavior of neurons in thalamocortical circuits (Pape 1996; Pape and McCormick 1989) , where it promotes spontaneous rhythmic activity like that associated with sleep states (Pape 1996) . We have demonstrated that native I h is strongly modulated by volatile anesthetics in motoneurons (Sirois et al. 1998 (Sirois et al. , 2002 , cells that are implicated in anesthetic-induced immobilization (Sonner et al. 2003a ). In addition, propofol inhibits I h in hippocampal pyramidal neurons and in the area postrema (Funahashi et al. 2004; Higuchi et al. 2003) . This suggests that the channels underlying I h may represent a point of convergence for multiple classes of anesthetics in various neuronal groups associated with anesthetic actions.
It is now clear that HCN channels represent the molecular basis for native I h (Ludwig et al. 1998; Santoro et al. 1997) . The four different HCN subunits exhibit distinct biophysical properties, and all are expressed to some degree in the mammalian CNS (Monteggia et al. 2000; Moosmang et al. 1999; Santoro et al. 2000) . Among these subunits, HCN1 and HCN2 are most prominently expressed in the CNS, with the HCN1 subunit more selectively localized than HCN2. In the studies reported here, we examined effects of propofol on native I h in mouse thalamocortical and cortical neurons and on cloned HCN subunits (mHCN1 and mHCN2) expressed heterologously. We find that propofol selectively inhibits fast HCN1 subunit-containing channels, like those that mediate I h in cortical pyramidal neurons, but does not diminish slower HCN2 channel currents, such as those in thalamocortical neurons.
M E T H O D S

Patch-clamp recordings from thalamic relay and cortical pyramidal neurons
Transverse brain slices from mice and rats of either sex (14 -22 days old) were prepared as described previously (Sirois et al. 1998; Talley et al. 2000) . Animals were decapitated under ketamine/xylazine anesthesia. The brain was rapidly removed from the cranium and submerged in an ice-cold substituted Ringer solution bubbled with 95% O 2 -5% CO 2 . The substituted Ringer solution contained (in mM) 260 sucrose, 3 KCl, 5 MgCl 2 , 1 CaCl 2 , 1.25 NaH 2 PO 4 , 26 NaHCO 3 , 10 glucose, and 1 kynurenic acid (Aghajanian and Rasmussen 1989) . Slices (200 -300 m) were cut using a microslicer (DSK 1500E; Dosaka, Tokyo, Japan). Before recording, slices were incubated at 37°C for 1 h and then subsequently at room temperature in a normal Ringer solution (mM) 130 NaCl, 3 KCl, 2 MgCl 2 , 2 CaCl 2 , 1.25 NaH 2 PO 4 , 26 NaHCO 3 , and 10 glucose, bubbled with 95% O 2 -5% CO 2 .
Patch-clamp electrodes were pulled from borosilicate glass (Warner Instruments) to a DC resistance of 3-5 M⍀ and coated with silicone elastomer (Sylgard 184; Dow Corning). Whole cell recordings were obtained from visually identified pyramidal neurons in layer V of somatosensory cortex and from relay neurons in the ventrobasal thalamic nucleus by using infrared differential interference contrast (IR-DIC) microscopy (Zeiss Axioskop FS Plus) and an Axoclamp 200B amplifier (Axon Instruments). Cell capacitance and series resistance (R, typically Ͻ20 M⍀) were compensated using the amplifier circuits (typically ϳ70% R compensation). In addition, R was continuously monitored on an oscilloscope between test pulses by using the seal test function on the amplifier. Only cells with stable R were included and any small changes in R were corrected on-line by using the compensation circuits of the amplifier.
For voltage-clamp recordings, the pipette solution contained (in mM) 120 KCH 3 SO 3 , 4 NaCl, 1 MgCl 2 , 0.5 CaCl 2 , 10 HEPES, 10 EGTA, 3 MgATP, and 0.3 GTP-Tris, pH 7.2 and 280 mosM. Currentclamp recordings were made with pipette solution containing (in mM) 17.5 KCl, 122.5 potassium gluconate, 1 MgCl 2 , 9 NaCl, 10 HEPES, 0.2 EGTA, 3 Mg-ATP, and 0.3 Tris-GTP, pH 7.2 and 272 mosM. Recordings were obtained at room temperature (22-24°C) while slices were continuously superfused (ϳ3-4 ml/min) with a solution containing (mM) 140 NaCl, 3 KCl, 2 MgCl 2 , 2 CaCl 2 , 10 HEPES and 10 glucose, pH 7.3. The properties of neuronal I h (i.e., maximal amplitude, voltage dependence) measured in slices using a HEPES-based bath solution equilibrated with room air (i.e., 21% O 2 ) are virtually identical to those obtained with a hyperoxic HEPES bath solution (100% O 2 ) or with normal Ringer solution bubbled with 95% O 2 -5% CO 2 (data not shown). All data were corrected for a measured liquid junction potential of 8 mV.
To block I h in some experiments, ZD-7288 (50 M; Tocris Cookson) was included in the pipette solution or CsCl was added to the bath (3 mM). We also included BaCl 2 (200 M) in most voltageclamp experiments to inhibit inwardly rectifying K ϩ currents in cortical and thalamic neurons. Where noted, tetrodotoxin (TTX at 0.5 M, Alomone Labs) was added to the perfusate to block action potentials and a bicuculline/strychnine cocktail (both at 30 M; from Sigma) was added to block GABA A and glycine receptor channels. Propofol (Sigma, St. Louis, MO) was prepared as a 100 mg/ml stock solution in ethanol and diluted in bath solution to the indicated concentrations; propofol was applied to neurons in the slice for ϳ5 min [5.1 Ϯ 0.5 (SD) min], a point at which we found inhibition of I h in cortical neurons was stable and maximal. In a subset of experiments on thalamocortical cells, propofol was perfused for 20 min before effects on I h were assessed.
Voltage-clamp recording of heterologously expressed mHCN channels
We obtained mHCN1 and mHCN2 from Drs. B. Santoro and S.A. Siegelbaum (Columbia University). The concatemeric HCN1-HCN2 construct was made by using overlap extension PCR to produce a PshAI-NheI fragment that spliced the final leucine of HCN1 directly in frame with the initiating methionine of HCN2 (Chen et al. 2005 ). The pGHE vector was used for oocyte expression and the pcDNA3 vector for expression in mammalian cells.
To prepare RNA for injection, in vitro transcription was performed with NheI-linearized DNA (HCN1), SphI-linearized DNA (HCN2), or XbaI-linearized DNA (HCN1-HCN2) using T7 RNA polymerase (Message Machine; Ambion, Houston, TX). Xenopus laevis oocytes (obtained from Drs. G. Kamatchi and H. Fang, University of Virginia) were injected with 46 nl of RNA (50 -200 ng/l) using a Nanoject microinjector (Drummond Scientific). After injection, oocytes were incubated at 17°C for 1-3 days in ND-96 solution, containing (in mM) 96 NaCl, 2 KCl, 1.8 CaCl 2 , 1 MgCl 2 , and 5 HEPES, pH 7.5, that was supplemented with 5% (wt/vol) gentamycin sulfate. Whole cell currents were recorded from oocytes in solution, containing (in mM) 107 KCl, 5 NaCl, 10 HEPES, 1 MgCl 2 , and 1 EGTA, pH 7.3, at room temperature with the two-microelectrode voltage-clamp technique using a Warner OC-725B amplifier (Warner Instruments, Hamden, CT). Voltage recording and current injecting electrodes were filled with 3 M KCl (1-3 M⍀).
HEK 293 cells were cultured using standard procedures and transiently transfected with HCN channel constructs, together with a GFP plasmid (pGreenLantern; GIBCO) using Lipofectamine 2000 reagent (Invitrogen). After transfection (1-2 days), whole cell recordings of HCN channel currents were obtained from HEK293 cells as described in the preceding text for neuronal recordings, except that the bath KCl concentration was raised to 25 mM (substituted equimolar for NaCl) (also see Chen et al. 2005) .
Data acquisition and analysis
Data were acquired using pCLAMP software (Axon Instruments) and a Digidata 1322A or a Digidata 1200 digitizer (Axon Instruments). For voltage-clamp recording, time-dependent hyperpolarization-activated currents (I h , HCN) were evoked with incrementing (⌬ Ϫ10 mV) hyperpolarizing pulses (3-4 s) from a holding potential of Ϫ40 or Ϫ50 mV, followed immediately by a step to fixed potential (Ϫ90 or Ϫ100 mV) to obtain tail currents. Current amplitude at each potential was taken as the difference between "instantaneous" currents, measured immediately after the capacitive transient, and the current at the end of hyperpolarizing voltage steps; maximal available current was determined at Ϫ120 or Ϫ130 mV. Tail currents were normalized, plotted as a function of the preceding hyperpolarization step voltage and fitted with Boltzmann curves for derivation of half-activation voltage (V1/2) by using a least squares analysis and the "solver" add-in of Excel (Microsoft). Time constants () were determined by fitting currents evoked during hyperpolarizing steps to a biexponential function. Results are presented as means Ϯ SE. Data were analyzed statistically using one-way ANOVA or Students t-test, as indicated; post hoc pairwise comparisons used Bonferroni's correction of the t-test (Excel or SigmaStat). Differences in mean values were considered significant if P Ͻ 0.05.
Histology
In all slice experiments, 0.2% biocytin (Sigma-Aldrich) was included in the patch electrode solution for subsequent morphological identification of recorded cells. Slices were fixed in 4% buffered paraformaldehyde solution for Ն24 h and then rinsed and incubated for 30 min with 1% H 2 O 2 and for 30 min with 0.5% Triton X-100. A 2-h incubation with avidin-biotin complex was followed by incubation in a diaminobenzidine substrate kit (both from Vector Labs, Burlingame, CA). Finally, slices were mounted onto gelatin-subbed slides and left to air dry overnight. Slices were dehydrated through graded ethanol and xylene and embedded in DPX mounting medium (BDH Laboratory Supplies); biocytin-stained neurons were visualized and photographed using an Axioskop microscope (Zeiss), equipped with a digital camera (Retiga 1300C, QImaging) and IPLab software (Scanalytics).
R E S U L T S
Propofol differentially modulates native I h in neocortical pyramidal neurons and thalamocortical neurons
We used whole cell patch-clamp recording in mouse brain slices to characterize hyperpolarization-activated currents (I h ) and their modulation by propofol in thalamocortical and neocortical neurons. Representative examples of cell morphology and I h recorded from those neurons are depicted in Fig. 1 . In a multipolar thalamocortical neuron from the ventral posteromedial nucleus (Fig. 1A) , currents evoked by hyperpolarizing voltage steps activated in a voltage-and time-dependent manner as expected of I h . In pyramidal neurons from somatosensory cortex (Fig. 1B) , I h was also observed during hyperpolarizing voltage steps; in cortical neurons, however, I h activated with faster kinetics than in thalamocortical neurons. Biexponential fits to I h obtained at fixed membrane potential of Ϫ120 mV revealed a variable slow component of I h that was accompanied by a fast component that accounted for the majority of current in both cortical and thalamocortical neurons (Ͼ60%). In most cortical neurons, I h activated with a fast time constant ( f ) that was Ͻ200 ms ( f ϭ 79.5 Ϯ 14.2 ms; n ϭ 9 of 12 cortical neurons recorded). Activation kinetics were much slower ( f Ͼ200 ms at Ϫ120 mV) in a subpopulation of cortical neurons ( f ϭ 434.6 Ϯ 16.2 ms; n ϭ 3) and in all thalamic neurons ( f ϭ 338.9 Ϯ 32.1 ms; n ϭ 10).
These distinct kinetic properties of I h typical of cortical and thalamic neurons are consistent with earlier recordings of I h from these two brain regions and with known patterns of HCN subunit expression in mouse cortex and thalamus (e.g., see Santoro et al. 2000) . In neocortical neurons, there is relatively high expression of fast-activating HCN1 subunits and moderate levels of slow-activating HCN2 subunits (Franz et al. 2000; Santoro et al. 2000) . In thalamocortical neurons, HCN1 is barely detectable and the slower HCN2 and HCN4 isoforms predominate (Notomi and Shigemoto 2004; Santoro et al. 2000) with the majority of the current (80 -90%) attributed to HCN2 .
We found that the intravenous general anesthetic, propofol, acts differently on I h in cortical and thalamic neurons. As exemplified in records from the representative cells of Fig. 1 , propofol (5 M, for ϳ5 min) had little effect on I h in thalamic neurons, but it caused a robust inhibition of I h in the group of cortical neurons with fast activation kinetics ( f Ͻ200 ms). The effect of propofol on I h may be seen more clearly as propofolsensitive currents (Fig. 1, right) , which were obtained by subtracting currents in the presence of propofol from those in control conditions. There was essentially no propofol-sensitive current in thalamic neurons, but we observed a substantial propofol-sensitive current with time and voltage dependence characteristic of I h in cortical neurons. The inhibition by propofol of fast-activating I h in cortical neurons was manifest in two prominent effects: a shift in voltage dependence of activation and a decrease in maximal available current. As depicted in Fig. 2A (left) , analysis of tail currents evoked at Ϫ100 mV after hyperpolarizing voltage steps to different membrane potentials revealed a propofolinduced hyperpolarizing shift in V1/2 by Ϫ9 Ϯ 0.9 mV (from Ϫ94.4 Ϯ 1.0 to 103.6 Ϯ 1.2 mV, n ϭ 9, P Ͻ 0.001). In addition, as shown in I-V relationships for I h in these cortical neurons ( Fig. 2A, right) , propofol reduced maximal timedependent current at the end of hyperpolarizing steps to Ϫ120 mV by 35.9 Ϯ 5.6% (P Ͻ 0.001); propofol also decreased input conductance at the holding potential by ϳ15%, as evident by the decreased slope of averaged "instantaneous" I-V curves (from 6.2 Ϯ 0.2 to 5.3 Ϯ 0.2 nS; P Ͻ 0.005, see Fig. 2A , inset). We also noted that current activation kinetics were slowed by propofol ( f at Ϫ120 mV from 79.5 Ϯ 14.2 to 112.5 Ϯ 26.2 ms, n ϭ 9, P Ͻ 0.05).
By contrast, propofol had no effect on I h voltage dependence (Ϫ98.3 Ϯ 0.6 and Ϫ97.8 Ϯ 0.9 mV in control and propofol; Fig. 2B , left), amplitude (0.5 Ϯ 0.0% activation; Fig. 2B , right) or on input conductance (2.6 Ϯ 0.6 and 2.5 Ϯ 0.5 nS in control and propofol) in thalamic neurons (n ϭ 5) or in the group of three cortical neurons with a slow form of I h (V1/2: Ϫ101.2 Ϯ 2.2 and Ϫ100.1 Ϯ 2.8 mV in control and propofol; amplitude inhibition: 3.7 Ϯ 0.1%). To rule out any concerns with the slow equilibration of propofol in slices (Bieda and MacIver 2004; Gredell et al. 2004) , we confirmed that propofol remained without effect on V1/2 or maximal amplitude of I h after a 20-min exposure to propofol (V1/2: Ϫ103.9 Ϯ 1.2 and Ϫ106.4 Ϯ 1.9 mV in control and propofol; amplitude inhibition: 7.6 Ϯ 3.3%; n ϭ 5, NS). It is noteworthy, however, that propofol did slow activation kinetics in all thalamocortical cells ( f at Ϫ120 mV from 338.9 Ϯ 32.2 to 474.1 Ϯ 81.2 ms, n ϭ 10, P Ͻ 0.05), and this effect was fully evident even after only 5 min of propofol application ( f at Ϫ120 mV from 409.8 Ϯ 39.2 to 637.5 Ϯ 126.1 ms, n ϭ 5, P Ͻ 0.05). These data indicate that although an action of propofol on activation kinetics can be discerned in thalamocortical neurons, the anesthetic does not modulate voltage dependence or maximal amplitude of I h under conditions identical to those in which the fast activating I h in cortical neuron is clearly inhibited.
We extended this analysis to motoneurons of the rat hypoglossal nucleus, which like mouse cortical pyramidal neurons, co-express high levels of HCN1 and moderate levels of HCN2 (Chen et al. 2005; Monteggia et al. 2000) and present a relatively fast form of I h ( f at Ϫ120 mV: 126.3 Ϯ 9.5 ms, n ϭ 7). In these motoneurons, 5 M propofol caused a hyperpolarizing shift in activation voltage (⌬V1/2 ϭ Ϫ5.8 Ϯ 2.3 mV, from Ϫ92.8 Ϯ 2.4 to Ϫ98.6 Ϯ 3.7 mV, P Ͻ 0.05) and a decrease in maximal current amplitude (20.6 Ϯ 6.0% inhibition, P Ͻ 0.05). Thus propofol modulated the fast-activating I h observed in rat motoneurons, although not quite as strongly as in mouse cortical neurons (approximately Ϫ10 mV shift in V1/2 and ϳ40% inhibition of peak current). FIG. 2. Modulation of fast-activating I h in cortical neurons includes a shift in activation gating and a decrease in maximal available current. The effect of propofol was determined on fast-activating I h (A) in cortical pyramidal neurons ( f Ͻ200 ms at Ϫ120 mV; n ϭ 9/12 neurons) and on slower-activating I h (B) in thalamocortical neurons ( f Ͼ200 ms at Ϫ120 mV; n ϭ 5/5 neurons). Under control conditions (■), and in the presence of propofol (‚), normalized tail currents were obtained after incrementing hyperpolarizing steps, averaged and fitted with Boltzmann curves (left). Likewise, time-dependent currents were measured at the end of each voltage step in control and propofol and plotted as a function of membrane potential. Propofol induced approximately Ϫ9 mV shift in V1/2 of I h activation and ϳ36% decrease in I h amplitude (at Ϫ120 mV) in cortical neurons but had no effect on I h in thalamocortical cells. The inset in A plots "instantaneous" currents evoked by hyperpolarizing voltage steps in cortical neurons, measured immediately after the capacitive transient but before development of the time-dependent current; propofol decreased the slope of the instantaneous I-V curve (i.e., the input conductance).
Propofol differentially modulates HCN1 and HCN2 channel subunits at clinically relevant concentrations
The data presented in the preceding text indicate that propofol inhibits current amplitude, slows activation kinetics, and shifts the voltage dependence of fast-activating I h in mouse cortical neurons but only modulates activation kinetics of the slower I h recorded from mouse thalamocortical cells. Because fast-activating HCN1 subunits are prominently expressed in cortex and slower-activating HCN2 subunits are predominant in thalamus Santoro et al. 2000) , we considered the possibility that these effects represent differential modulation of channels containing HCN1 and HCN2 subunits.
To test this hypothesis, we recorded currents from cloned mHCN1 and mHCN2 channel subunits expressed in Xenopus oocytes (Fig. 3) . As reported, these two mHCN subunits produce homomeric channels with different activation properties: mHCN2 currents activate more slowly and at more hy- FIG. 3. Propofol modulates HCN channels containing the mHCN1 subunit. A: sample currents from Xenopus oocytes expressing mHCN1, mHCN2, or a tandem-linked heteromeric mHCN1-HCN2 construct evoked by hyperpolarizing voltage steps from Ϫ40 to Ϫ130 mV before, during, and after exposure to propofol (5 M); conditioning voltage steps were of different duration for the three constructs (2, 3, and 4 s for HCN1, HCN1-HCN2, and HCN2, respectively) and followed by a step to Ϫ90 mV for tail current analysis. B: activation curves were fitted according to the Boltzmann equation to normalized, averaged tail currents (left) and averaged steady-state I-V curves were obtained from currents at the end of the voltage steps (right) under control conditions (ᮀ), during exposure to 5 M propofol (■) and after recovery (‚) for HCN1, HCN2. or a linked HCN1-HCN2 construct. C: effect of propofol (5 M) on half-activation potential (⌬V1/2) and maximal current amplitude was determined in individual oocytes expressing the indicated constructs under control conditions and averaged (ϮSE, n ϭ 7, 8 and 6 for HCN1, HCN2, and HCN1-HCN2). *, significantly different from HCN2, P Ͻ 0.05 by ANOVA. D: concentration-response data for propofol (0.5, 5 and 50 M) modulation of HCN1-HCN2 heteromeric channel currents in oocytes; a significant hyperpolarizing shift in V1/2 (left) and inhibition of current amplitude (right) were already evident at only 5 M propofol. *, significantly different from 0.5 M, P Ͻ 0.05 by ANOVA.
perpolarized potentials than mHCN1 currents Kaupp and Seifert 2001; Santoro and Tibbs 1999) . We found that channels containing these subunits also differed in their modulation by propofol. In oocytes expressing mHCN1 subunits, propofol (5 M) caused a hyperpolarizing shift in voltage dependence of activation (⌬V1/2 of Ϫ14.8 Ϯ 1.6 mV, from Ϫ86.3 Ϯ 2.2 to Ϫ100.6 Ϯ 1.3 mV, n ϭ 6, P Ͻ 0.005) and a decrease in maximal current amplitude of 27.9 Ϯ 4.0% (P Ͻ 0.05; Fig. 3C ). These effects are similar to those observed on native I h in cortical neurons. On the other hand, propofol induced little effect on voltage dependence or amplitude of mHCN2 channel currents expressed in oocytes (V1/2: Ϫ94.4 Ϯ 3.6 and Ϫ96.8 Ϯ 3.5 mV in control and propofol; amplitude inhibition: 2.5 Ϯ 2.0%; Fig. 3C ). For both mHCN1 and mHCN2, propofol caused a slowing of current activation ( f at Ϫ120 mV from 66.0 Ϯ 4.4 to 238.2 Ϯ 16.1 ms, n ϭ 5; and from 304.6 Ϯ 35.2 to 438.0 Ϯ 71.0 ms, n ϭ 5; both P Ͻ 0.05).
These data indicate that the intravenous anesthetic propofol differentially inhibits HCN1 and HCN2 homomeric channels expressed in Xenopus oocytes. We confirmed these results in a mammalian expression system. In HEK293 cells expressing HCN1 channels, propofol shifted V1/2, decreased current amplitude and slowed activation kinetics (⌬V1/2: Ϫ20.5 Ϯ 1.7 mV; amplitude inhibition: 16.5 Ϯ 4.1%; f at Ϫ120 mV from 22.4 Ϯ 5.5 to 106.8 Ϯ 9.4 ms; n ϭ 7, all P Ͻ 0.05); these effects of propofol on HCN1 channels were significantly greater than on HCN2-expressing cells (⌬V1/2: Ϫ5.0 Ϯ 0.4 mV; amplitude inhibition: 2.5 Ϯ 2.8%; n ϭ 9, P Ͻ 0.05), except for the slowing of current activation that was again prominent with HCN2 channels in HEK293 cells ( f at Ϫ120 mV from 225.8 Ϯ 29.1 to 335.1 Ϯ 50.8 ms; n ϭ 8, P Ͻ 0.01). We have reported that distinct inhibitory effects of an inhaled anesthetic, halothane, on HCN1 and HCN2 homomeric channels reflect different basal properties of the channels that can be overcome by cAMP modulation (Chen et al. 2005) . However, addition of saturating cAMP (50 M) to pipettes used to record HCN2 currents in HEK293 cells did not enhance propofol effects on either V1/2 or current amplitude (data not shown, n ϭ 5). Thus cAMP did not uncover additional latent inhibition of HCN2 channels by propofol.
Propofol inhibits heteromeric HCN1-HCN2 channels
A number of previous studies have demonstrated that HCN subunits can form heteromeric channels (Chen C. et al. 2001; Much et al. 2003; Ulens and Tytgat 2001) . Therefore we prepared a linked mHCN1 and mHCN2 cDNA and expressed that construct in oocytes to test effects of propofol on heteromeric HCN channels (Fig. 3) . By using this concatenated construct, we were able to record from a homogenous population of HCN1-HCN2 heterotetrameric channels with a defined 1:1 stoichiometry; this approach yields macroscopic currents nearly identical to those obtained by co-injecting HCN1 and HCN2 subunit mRNAs in equal proportions (Chen C. et al. 2001; Ulens and Tytgat 2001) .
As expected, we found that the linked HCN1-HCN2 heteromeric channel currents displayed kinetic and voltage-dependent properties intermediate to those of homomeric mHCN1 and mHCN2 channels (Fig. 3, A and B) (Chen C. et al. 2001; Ulens and Tytgat 2001) . Likewise, effects of propofol on linked mHCN1-HCN2 heteromeric channel currents were also intermediate between those of mHCN1 and mHCN2 channels, inducing a hyperpolarizing shift in V1/2 of Ϫ11.6 Ϯ 2.6 mV (from Ϫ88.2 Ϯ 1.3 to Ϫ100.2 Ϯ 2.2 mV; n ϭ 5, P Ͻ 0.005) and a decrease of maximal current amplitude by 20.2 Ϯ 4.3% (P Ͻ 0.05; Fig. 3C) ; propofol also cause a slowing of HCN1-HCN2 current activation ( f at Ϫ120 mV from 105.7 Ϯ 6.1 to 215.3 Ϯ 13.6 ms, n ϭ 5, P Ͻ 0.005). Again, we confirmed these results in HEK293 cells expressing HCN1-HCN2 channels (⌬V1/2: Ϫ10.2 Ϯ 0.9 mV; amplitude inhibition: 10.6 Ϯ 3.5%; f at Ϫ120 mV from 71.5 Ϯ 12.8 to 134.3 Ϯ 16.9 ms; n ϭ 8, all P Ͻ 0.05). Thus effects of propofol on heteromeric HCN channels were also similar to those observed on I h from most cortical neurons. Moreover, these data indicate that propofol inhibits either homomeric or heteromeric channels that contain HCN1 subunits.
We tested effects of propofol on HCN1-HCN2 heteromeric channels expressed in oocytes over a range of concentrations that encompasses those achieved clinically (0.5-50 M). Propofol induced a hyperpolarizing shift in the voltage dependence of activation (Fig. 3D, left) and suppressed amplitude of heteromeric HCN channel currents (Fig. 3D , right) in a dosedependent manner. There was little effect of propofol at 0.5 M but a significant shift in V1/2 and a decrease in maximal current amplitude both at 5 M (⌬V1/2: Ϫ11.0 Ϯ 1.9 mV; amplitude inhibition: 20.2 Ϯ 3.1%, n ϭ 6) and at 50 M (⌬V1/2: Ϫ16.4 Ϯ 1.4 mV; amplitude inhibition: 29.3 Ϯ 4.3%, n ϭ 5). These results indicate that propofol inhibits heteromeric HCN channels in dose-dependent manner over a clinically relevant concentration range.
Propofol modulates thalamic and cortical neuron I h with fast activation kinetics indicative of channels containing HCN1 subunits
A summary of data relating activation kinetics of cloned HCN channels and native neuronal I h to effects of propofol on voltage dependence of activation and maximal current amplitude is provided in Fig. 4 . As described in the preceding text, activation kinetics of native I h currents in individual neurons and of HCN channel currents expressed in oocytes were analyzed by using biexponential fits to currents obtained at Ϫ120 mV. The time constant of the fast exponential component ( f ) from cortical and thalamic neurons was correlated with both the shift in V1/2 and the decrease in maximal current amplitude by propofol in a manner consistent with averaged data from mHCN channel currents expressed in Xenopus oocytes. Thus propofol induced a hyperpolarizing shift in V1/2 and inhibition of I h amplitude in all cells with fast activation kinetics ( f Ͻ200 ms), including the majority of cortical neurons and oocytes expressing either mHCN1 or mHCN1-2. In all neurons with fast activating I h , the shift in V1/2 and the amplitude inhibition by propofol was greater than the largest effect of propofol in HCN2-expressing oocytes. On the other hand, there was little effect of propofol on V1/2 or current amplitude of the slowly activating I h in thalamic neurons, the response of which resembled that observed in oocytes expressing mHCN2. Note, also, that the few cortical neurons that expressed a slow form of I h were also relatively insensitive to propofol (Fig. 4 , see shaded triangles with f Ͼ200 ms). These data indicate that native I h currents with fast kinetics, presum-ably those containing HCN1 subunits, are subject to these inhibitory actions of propofol.
Propofol differentially modulates instantaneous HCN channel current
An instantaneous component of current, in addition to the voltage-and time-dependent component, has been observed in recordings from cloned HCN channels (Ludwig et al. 1998; Macri and Accili 2004; Mistrik et al. 2005; Proenza et al. 2002) . This current component represents tonic activation of HCN channels at holding potentials depolarized to the threshold for voltage-dependent activation and, at least for HCN2 channels, can represent ϳ10% of the total available current (Chen et al. J. 2001; Decher et al. 2004) . We therefore tested if propofol inhibits instantaneous currents from HCN channels and if it does so in a subunit-specific manner. In HEK293 cells expressing HCN1, HCN2, and HCN1-HCN2, we measured input conductance as the slope of I-V relationships from instantaneous currents (i.e., measured immediately after the capacitive transient and before development of time-dependent currents) evoked by hyperpolarizing voltage steps from a holding potential of Ϫ40 mV. As is evident in Fig. 5 , instantaneous currents generated from all three HCN constructs were inhibited by 3 mM CsCl, an HCN channel blocker. Importantly, and consistent with the differential effects we observed on voltage-and time-dependent HCN currents, propofol inhibited tonically active currents from HCN1 and HCN1-HCN2 channels but had no effect on instantaneous HCN2 channel currents. When expressed relative to the Cs ϩ -sensitive input conductance (a measure of the tonically-active HCN current), propofol inhibited ϳ50% of instantaneous HCN1 current, ϳ30% of instantaneous HCN1-HCN2 current, but only ϳ5% of the instantaneous HCN2 current. These data confirm earlier observations of tonically active HCN channel currents at depolarized membrane potentials (Ludwig et al. 1998; Macri and Accili 2004; Mistrik et al. 2005; Proenza et al. 2002) , and they demonstrate that propofol robustly and preferentially inhibits tonic currents from channels containing HCN1 subunits.
Propofol causes membrane hyperpolarization and decreases excitability in cortical neurons by inhibition of I h
We next asked, for neocortical neurons where mHCN1 transcripts are prominent and where we observed potent inhibition of I h by propofol, whether propofol-induced modulation of I h results in a significant inhibition of cortical neuron excitability. To determine effects of propofol on cell excitability and resting potential, we performed continuous recordings of voltage responses elicited by rectangular depolarizing current injection, in the presence of GABA A and glycine receptor antagonists (bicuculline and strychnine, both at 30 M). As shown in Fig. 6 for a representative cortical pyramidal neuron, propofol caused hyperpolarization of resting membrane potential that averaged 4.1 Ϯ 0.1 mV (n ϭ 9), and it decreased cell excitability, even when membrane potential was returned to control levels by DC current injection. On average, propofol increased the current necessary to induce action potential discharge from 0.44 Ϯ 0.02 nA to 0.72 Ϯ 0.02 in 5 M propofol (n ϭ 5, P Ͻ 0.05) and to 0.54 Ϯ 0.02 nA in propofol when membrane potential was returned to control by depolarizing DC current injection.
To confirm that the propofol-induced hyperpolarization of membrane potential was caused by suppression of I h , we studied cortical neurons with or without ZD-7288 (50 M), a potent I h channel antagonist (Bosmith et al. 1993) , in the pipette solution (Fig. 7) . Again, recordings were performed in the presence of bicuculline and strychnine to block GABA A and glycine channels. In a cell recorded without ZD-7288 in the pipette (Fig. 7A, left) , propofol induced a membrane hyperpolarization, as described in the preceding text (approximately Ϫ4 mV; see Fig. 7D , for averaged data). Propofol also increased input resistance (ϳ9%, from 142.5 Ϯ 5.5 to 154.5 Ϯ 5.9 M⍀; n ϭ 8, P Ͻ 0.005) and eliminated the rebound action potential discharge after the hyperpolarizing current pulse (Fig.  7A, right) . Note that the depolarizing "voltage sag" and rebound potential, which correspond to activation and deactivation of I h , respectively were not eliminated by propofol. This likely reflects the partial nature of propofol-induced inhibition of I h as well as enhanced activation of the residual I h during the FIG. 4. Propofol modulates fast-activating HCN channels and neuronal I h . The relationship between activation kinetics of neuronal I h or HCN currents and the shift in V1/2 (A) or inhibition of maximal current amplitude (B) induced by propofol (5 M). Activation data were obtained from biexponential fits at Ϫ120 mV, and the time constant ( f ) describing the fastest (and largest) current component was plotted together with data from individual neurons or averaged data (ϮSE) from oocytes expressing the indicated constructs. In most cortical neurons (}), or in oocytes expressing HCN1 and HCN1-HCN2 channels, currents activated with a f Ͻ200 ms (Ӈ). In these cells, propofol induced a shift in V1/2 or a current inhibition that was greater than the largest effect measured in all but 1 thalamic neuron (‚) or in any HCN2-expressing oocyte ( ⅐ ⅐ ⅐ ; ⌬V1/2 ϭ 4.5 mV: inhibition ϭ 12.4%). Note that there was little effect of propofol on the three cortical neurons with a slow form of I h ( f Ͼ200 ms). current pulse as a result of the membrane hyperpolarization and increased R N that also accompanied propofol actions.
In cells recorded with 50 M ZD-7288 in the pipette solution, we observed a time-dependent increase in input resistance (ϳ19%, from 115.1 Ϯ 1.0 to 136.7 Ϯ 2.7 M⍀; n ϭ 4, P Ͻ 0.05) and hyperpolarization of membrane potential (Fig. 6B, left) that proceeded for ϳ5 min after whole cell access; after reaching a steady-state, membrane potential in FIG. 5. Propofol inhibits a Cs ϩ -sensitive instantaneous HCN channel current. A: instantaneous I-V relationships were obtained from a holding potential of Ϫ40 mV in HEK293 cells expressing HCN1 (left), HCN1-HCN2 (middle), and HCN2 (right) under control conditions (F), in the presence of 5 M propofol (}), and 3 mM CsCl (■). -, linear fits through averaged data (ϮSE; n ϭ 7, 10, and 9 for HCN1, HCN2, and HCN1-HCN2, respectively), representing the input conductance at Ϫ40 mV. B: input conductance was determined from instantaneous I-V curves in individual cells expressing the HCN channel constructs, and averaged for each condition as indicated. Propofol decreased input conductance in HCN1-and HCN1-HCN2-expressing cells but not in cells expressing HCN2; cesium inhibited the tonic current in all HCN transfected cells (*, P Ͻ 0.05 vs. control). FIG. 6. Propofol causes membrane hyperpolarization and decreased excitability in cortical neurons independent of the GABA A receptor. A: whole cell current-clamp recording of cortical neuron membrane potential before and during bath application of propofol (5 M) in the continued presence of bicuculline and strychnine (both at 30 M). At a point near the maximal hyperpolarization induced by propofol (⌬ approximately Ϫ4 mV), membrane potential was restored to control levels (approximately Ϫ60 mV) by using depolarizing DC current injection. Vertical deflections are truncated membrane responses to periodic injections of depolarizing current pulses. B: spike firing responses to rectangular depolarizing current pulses (0.5 to 0.9 nA; from points indicated in A are expanded. By comparison to control (a), depolarizing current pulses of greater magnitude were required to evoke spike firing in the presence of propofol, whether the cell was returned to control membrane potential (b) or from the maximal propofolinduced hyperpolarization (c).
cells recorded with ZD-7288 was hyperpolarized ϳ12 mV relative to control cells (Ϫ69.9 Ϯ 1.6 vs. Ϫ58.3 Ϯ 3.1 mV; n ϭ 4 and n ϭ 8, P Ͻ 0.05; see Fig. 7C ). The time course of membrane hyperpolarization mirrors the time-dependent, and essentially complete, inhibition of I h by intracellular ZD-7288 measured under voltage clamp in these neurons (data not shown). In the current-clamp recordings of Fig. 7B , the abolition of I h by ZD-7288 is evident by the loss of the depolarizing voltage sag (3) and rebound potential (compare voltage responses at 0 and 6 min, Fig. 7B, right) . Consistent with the idea that propofol causes membrane hyperpolarization by inhibition of I h , we found that propofol had no effect on membrane potential or input resistance when I h was eliminated by intracellular ZD-7288, (Fig. 7B) . As is clear from averaged results presented in Fig. 7 , C and D, the I h blocker ZD-7288 itself caused a significant hyperpolarization (C), and it occluded further effects on membrane potential by propofol (D).
We found that the I h blocker Cs ϩ (3 mM, bath applied) also caused membrane hyperpolarization (Ϫ7.6 Ϯ 1.6 mV) and strongly increased R N (ϳ110%, from 121.5 Ϯ 11.6 to 250.4 Ϯ 34.0 M⍀; P Ͻ 0.05) in individual cortical neurons (n ϭ 4). Both Cs ϩ and ZD-7288 caused nearly identical decreases in I h and cortical neuron input conductance (ϳ50%) under voltage clamp when the compounds were applied in the bath in the presence of 200 M Ba 2ϩ (data not shown) So, the larger increase in R N by Cs ϩ in these current-clamp experiments, by comparison to ZD-7288, likely reflects two factors: additional block by Cs ϩ of inwardly rectifying K ϩ currents and partial block of I h by intracellular ZD-7288 at the earliest time point in the recording. Unfortunately, because cortical neurons became increasingly unstable in the continued presence of Cs ϩ , even in the presence of TTX and a glutamate receptor blocker (kynurenate, 1 mM), we were unable to test an effect of propofol after blocking I h with Cs ϩ . Overall, these data indicate that I h contributes a substantial persistent inward current near resting membrane potential in cortical pyramidal neurons, and that inhibition of I h by propofol can decrease excitability and alter electroresponsive properties of these neurons.
D I S C U S S I O N
In this study, we demonstrated that propofol inhibits a form of I h with relatively fast activation kinetics ( f Ͻ 200 ms) that is expressed in mouse cortical pyramidal neurons or rat motoneurons. The inhibition of neuronal I h by propofol was evident at a clinically relevant concentration (5 M) and involved a hyperpolarizing shift in voltage dependence of activation, a decrease in maximal available current and a slowing of activation kinetics. On the other hand, propofol had no effect on V1/2 of activation or maximal current amplitude of a slower activating form of I h expressed in thalamocortical relay neurons ( f Ͼ 200 ms), although kinetic slowing was evident. The different kinetics of I h observed in mouse cortical and thalamocortical neurons agrees with prior electrophysiological work (Santoro et al. 2000) ; it is also consistent with greater expression of fast-activating HCN1 subunits in mouse cortex (particularly in layer V pyramidal neurons) and with FIG. 7. Inhibition of I h accounts for membrane hyperpolarization by propofol in cortical neurons. Whole cell current-clamp recordings were performed to test effects of the I h blocker, ZD-7288 on cortical neuron membrane potential and response to propofol (5 M) in the continued presence of bicuculline and strychnine (both at 30 M). A: representative time course of membrane hyperpolarization (from Ϫ64 to Ϫ68 mV) induced by propofol in a cortical neuron recorded without ZD-7288 (left); voltage responses to hyperpolarizing current pulses include a "sag" characteristic of I h activation (3) and a rebound spike that is absent in the presence of propofol (right). B: time course of membrane potential in a representative cortical neuron recorded with a pipette containing ZD-7288 (50 M). A progressive hyperpolarization (from Ϫ66 to Ϫ74 mV) began immediately after obtaining whole cell access (left), after which application of propofol had no additional effect on membrane potential. Note that the depolarizing sag (3) and rebound potential that was evident in initial voltage responses to hyperpolarizing current pulses (0 min) disappeared in conjunction with the membrane hyperpolarization (6 min), indicating that I h was blocked by ZD-7288 at the time of propofol application (right). C: averaged membrane potential in cortical neurons recorded with normal internal solution and with pipettes containing ZD-7288 (*, P Ͻ 0.05 by unpaired t-test), D: averaged propofol-induced hyperpolarization in cortical neurons recorded with normal internal solution and with pipettes containing ZD-7288. (*, P Ͻ 0.001 by unpaired t-test) higher densities of slower activating HCN2 and HCN4 subunits in thalamic relay nuclei (Santoro et al. 2000) . Accordingly, propofol modulated cloned homomeric HCN1 or heteromeric HCN1-HCN2 channel currents in ways reminiscent of its effects on I h in cortical neurons, causing a negative shift in V1/2, decreasing maximal current amplitude and slowing activation kinetics. Also consistent with actions of the anesthetic on native I h in thalamocortical neurons, we found that cloned HCN2 homomeric channels were relatively insensitive to propofol, showing only kinetic slowing with no change in voltage dependence or maximal amplitude. Propofol suppressed excitability in cortical neurons, causing membrane hyperpolarization and decreasing action potential discharge. These actions of propofol were due to inhibition of I h because they persisted when GABA A and glycine receptors were blocked but were completely occluded when I h was inhibited by ZD-7288. In sum, these results indicate that modulation of I h by propofol in cortical pyramidal cells and motoneurons, and perhaps in other HCN1-expressing cells, may contribute to its GABA-independent anesthetic and/or anticonvulsant actions (Higuchi et al. 2003) .
Any suggestion of a role for I h inhibition in the clinical actions of propofol presupposes modulation of the channels over a concentration range that is achieved clinically. In this respect, circulating concentrations of propofol at which 50% of patients fail to respond to verbal command and skin incision are 3.3 g/ml (18 M) and 15.2 g/ml (85 M), respectively (Smith et al. 1994) . Because Ͼ95% of propofol is bound to serum proteins, free fractions of propofol that produce these anesthetic actions are expected to range from 1 to 4.5 M, but may be as high as 10 M (Shyr et al. 1995) . We showed that inhibitory effects of propofol on cortical I h and on HCN1 subunit-containing channels occur within this clinically relevant concentration range, with near maximal effects at 5 M. If access of the drug to the slice is limited, as has been suggested (Bieda and MacIver 2004; Gredell et al. 2004) , the actual effective concentration of propofol at the channel may be even lower than the bath concentrations we report.
We found a strong inhibition of I h by propofol in pyramidal neurons of the neocortex similar to that previously reported in CA1 hippocampal pyramidal neurons, although higher concentrations of propofol (50 M to 1 mM) were necessary for propofol actions on hippocampal I h (Funahashi et al. 2001 (Funahashi et al. , 2004 Higuchi et al. 2003 ). The reason for this different propofol sensitivity in pyramidal neurons from neocortex and hippocampus, despite generally similar HCN expression and I h properties in the two cell types, remains to be determined. As with layer V neocortical neurons, CA1 hippocampal pyramidal neurons appear to express HCN1 predominantly, along with HCN2, and a corresponding native I h with fast activation kinetics (fast activation Ͻ100 ms at approximately Ϫ100 mV) (Santoro et al. 2000) . Given joint expression of both HCN1 and HCN2 subunits in cortical and hippocampal pyramidal neurons, it is likely that I h in these cells includes a contribution from homomeric HCN channels as well as heteromeric HCN1-HCN2 channels. Importantly, we showed that these heteromeric HCN1-HCN2 channels also produce currents with fast kinetics that are modulated by propofol.
We found that propofol caused membrane hyperpolarization near resting membrane potential (i.e., at Ϫ60 mV) and decreased excitability in neocortical neurons in a ZD-7288-sensitive manner, as also observed in hippocampal CA1 pyramidal neurons (Higuchi et al. 2003) . This ZD-7288-sensitive action of propofol at relatively depolarized membrane potentials likely involves inhibition of a tonic component of I h because we find that only ϳ5% of the voltage-and timedependent current component is available at Ϫ60 mV (e.g., see Fig. 2A ). Consistent with this, we showed that propofol can robustly inhibit tonic currents from HCN1 subunit-containing channels. In addition, it is possible that inhibition of dendritic I h by propofol could enhance temporal summation of synaptic inputs in those neurons, especially those impinging on distal dendrites where I h channels are most dense (Magee 2000; Migliore and Shepherd 2002) . Other ionic mechanisms likely also contribute to effects of propofol on cortical neuron excitability. For example, propofol can inhibit apamin-sensitive calcium-activated K ϩ currents (Ying and Goldstein 2005) , and it enhances synaptic as well as tonically active GABA A currents in neocortical and hippocampal neurons (Bieda and MacIver 2004; Orser et al. 1994 ). So, it seems that multiple ion channel targets-intrinsic and synaptic, acting tonically and phasically-could contribute to complex integrated actions of propofol in cortical neurons and elsewhere.
As mentioned in the preceding text (see INTRODUCTION) , although some anesthetic actions of propofol certainly involve enhancement of GABA A receptor (Jurd et al. 2003) , existing pharmacological and genetic evidence leave open the possibility that other targets may also be important. In this respect, a role for HCN channels in hypnotic or amnestic effects of general anesthetics is intriguing. Thalamocortical circuits are implicated in the sleep-like actions of anesthetics (Alkire et al. 2000) and inhibition of I h in thalamic relay neurons and cortical neurons is associated with sleep-like rhythmic network activity (Pape 1996; Pape and McCormick 1989) . Our data suggest that any induction by propofol of a sleep-like state that involves actions on I h within thalamocortical circuits will engage primarily the cortical neuron component, where its actions on I h were most prominent. However, it is also possible that the propofol-induced slowing of I h activation kinetics we observed in cortical and thalamocortical relay neurons could also modulate rhythmic thalamocortical activity. In addition, I h underlies a "pacemaker" current for generating the theta-like oscillations in entorhinal pyramidal neurons that provide a synchronizing mechanism important in memory formation (Dickson et al. 2000) . Inhibition of cortical neuronal I h by propofol could disrupt such network coherence and thereby contribute to amnestic actions of the drug.
In conclusion, we have found that propofol inhibits the neuronal pacemaker current, I h , in cortical pyramidal neurons at clinically relevant concentrations. These currents contribute to setting membrane potential and input resistance, they modulate dendritic integration, and they are crucial for multiple cortical rhythms (Pape 1996) . These data are consistent with accumulating evidence that general anesthetics do not simply provide widespread suppression of neuronal excitability. Rather it is likely that anesthetic drugs target multiple distinct types of ion channel at specific sites where they commandeer certain aspects of normal neuronal activity patterns to generate the anesthetic state. The precise contribution of HCN channel inhibition to overall anesthetic actions in cortical neurons will require modeling in simulated networks or experiments in animals with targeted disruption of HCN subunits.
